13 Einträge gefunden

1. Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

   1. Weisel, Katja
   2. Dimopoulos, Meletios A
   3. San-Miguel, Jesús
   4. Paner, Agne
   5. Engelhardt, Monika
   6. Taylor, Fiona
   7. Lord-Bessen, Jennifer

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA

   1. Cavo, Michele
   2. San-Miguel, Jesus F F
   3. Usmani, Saad Z
   4. Weisel, Katja C
   5. Dimopoulos, Meletios A A
   6. Avet-Loiseau, Hervé
   7. Paiva, Bruno

   2022 - Forschungsinformationssystem des UKE
3. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

   1. Dimopoulos, Meletios A
   2. Richardson, Paul G
   3. Bahlis, Nizar J
   4. Grosicki, Sebastian
   5. Cavo, Michele
   6. Beksaç, Meral
   7. Legieć, Wojciech

   2022 - Forschungsinformationssystem des UKE
4. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

   1. Mateos, Maria-Victoria
   2. Weisel, Katja
   3. De Stefano, Valerio
   4. Goldschmidt, Hartmut
   5. Delforge, Michel
   6. Mohty, Mohamad
   7. Cavo, Michele

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

   1. Ludwig, Heinz
   2. Boccadoro, Mario
   3. Moreau, Philippe
   4. San-Miguel, Jesus
   5. Cavo, Michele
   6. Pawlyn, Charlotte
   7. Zweegman, Sonja

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy

   1. Chari, Ajai
   2. Munder, Markus
   3. Weisel, Katja
   4. Jenner, Matthew
   5. Bygrave, Ceri
   6. Petrucci, Maria Teresa
   7. Boccadoro, Mario

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations

   1. Rosiñol, Laura
   2. Beksac, Meral
   3. Zamagni, Elena
   4. Van de Donk, Niels W C J
   5. Anderson, Kenneth C
   6. Badros, Ashraf
   7. Caers, Jo

   2021 - Forschungsinformationssystem des UKE
8. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

   1. Ludwig, Heinz
   2. Sonneveld, Pieter
   3. Facon, Thierry
   4. San-Miguel, Jesus
   5. Avet-Loiseau, Hervé
   6. Mohty, Mohamad
   7. Mateos, Maria-Victoria

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
9. Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis

   1. Dimopoulos, Meletios A
   2. Niesvizky, Ruben
   3. Weisel, Katja
   4. Siegel, David S
   5. Hajek, Roman
   6. Mateos, María-Victoria
   7. Cavo, Michele

   2020 - Forschungsinformationssystem des UKE
10. Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

    1. Goldschmidt, Hartmut
    2. Dimopoulos, Meletios A
    3. Rajkumar, S Vincent
    4. Weisel, Katja C
    5. Moreau, Philippe
    6. Chng, Wee-Joo
    7. Mikala, Gábor

    2020 - Forschungsinformationssystem des UKE
11. Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies

    1. Mateos, Maria-Victoria
    2. Spencer, Andrew
    3. Nooka, Ajay K
    4. Pour, Ludek
    5. Weisel, Katja
    6. Cavo, Michele
    7. Laubach, Jacob P

    2020 - Forschungsinformationssystem des UKE
12. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

    1. Palumbo, Antonio
    2. Bringhen, Sara
    3. Ludwig, Heinz
    4. Dimopoulos, Meletios A
    5. Bladé, Joan
    6. Mateos, Maria V
    7. Rosiñol, Laura

    2011 - Forschungsinformationssystem des UKE
13. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

    1. Cavo, Michele
    2. Rajkumar, S Vincent
    3. Palumbo, Antonio
    4. Moreau, Philippe
    5. Orlowski, Robert
    6. Bladé, Joan
    7. Sezer, Orhan

    2011 - Forschungsinformationssystem des UKE